Developing and manufacturing long-lasting injectable hydrogels in our state-of-the-art facility in Denmark

Tour our state-of-the-art
manufacturing facility

Inspect our extensive
global certifications

Read our quality
promises to you

We have over 20 years experience developing and manufacturing our patented 2.5% iPAAG.

An injectable used in treatments that provide years of symptom relief for patients.

2.5% iPAAG is an injectable polyacrylamide hydrogel known for its unique structure, comprising of 2.5% cross-linked polyacrylamide and 97.5% water.

It is a long-lasting bio-scaffold that promotes the smooth integration and incorporation of surrounding biological tissues.

Unlike other injectables, 2.5% iPAAG is non-degradable and hydrophilic, which allows it to maintain its structure and volume post-injection providing long-lasting symptom relief for patients in a wide range of indications.

Our state-of-the-art facility in Denmark ensures manufacturing consistent high quality products

Dedicated and custom-built for manufacturing 2.5% iPAAG
Automated processes ensure reliability and quality in every single syringe
Our highly skilled operators and engineers ensure that our syringes are tightly monitored and tested against comprehensive release specifications
Manufactured to strict standards to meet FDA and EU regulations

Provide years of symptom relief with a single treatment

Expand your minimally invasive treatment options
Allow patients to live their most active lives
Deliver symptom relief for many years

A unique hydrogel that provides long-lasting symptom relief across different therapy areas

If there are other indications not shown here that your patients could benefit from, we encourage you to contact our specialists for expert guidance and support.

Orthopedics

Animal Health

Urinary Incontinence

Our promises to you

Biocompatible

Rigorously tested to surpass strict industry requirements, securing global approvals that set new industry benchmarks^1-3

Bio-integrated

Unlike other injectables, 2.5% iPAAG is non-degradable and fully integrates with surrounding tissue^1-4

Providing significant benefit

We will only enter markets where we believe 2.5% iPAAG addresses a signiﬁcant clinical need and can offer clinically-meaningful results

Clinically proven

We maintain 2.5% iPAAG’s market-leading efficacy and safety profile by conducting robust clinical research for each of the therapeutic areas we enter

Manufactured in our state-of-the-art facility

We will continue to individually inspect each 2.5% iPAAG injectable in our Danish manufacturing facility so that every syringe is identical to the next in quality and composition

Over 1.4 million doses

delivered globally since 2003

Want to learn more about how 2.5% iPAAG can help you?

Eliminate the frustration with injectables that have short-lasting and unpredictable outcomes

Speak to a 2.5% iPAAG expert

Get in contact with us and book a time that works for you

Learn about the 2.5% iPAAG injectable

Choose the injectable suitable for your patients

Trial 2.5% iPAAG

Arrange a date to trial 2.5% iPAAG

Contura International A/S

*2.5 iPAAG is an injectable polyacrylamide hydrogel known for its unique composition, comprising of 2.5% cross-linked polyacrylamide and 97.5% water.

Arthrosamid is a registered trademark of Contura International A/S.

Contura Vet is a registered trademark of Contura Vet Ltd.